H.R. 3884 · 118th Congress (2023–2025)
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023
This bill reauthorizes through FY2028 the Sickle Cell Disease Treatment Demonstration Program, which supports efforts to improve treatment and prevention of sickle cell disease and complications from that disease. (Sickle cell disease is an inherited blood disorder that can lead to pain, anemia, infections, and stroke.)
!--tinycomments|2.1|data:application/json;base64,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-->Show official title
To amend title XI of the Public Health Service Act to reauthorize the program providing for sickle cell disease and other heritable blood disorders research, surveillance, prevention, and treatment.
Expired in Senate committee
Derived from the legislative history, not an official disposition.
Latest actionReferred to committee
This bill’s path
474 days after it was introduced
This is H.R. 3884’s recorded path, not a universal congressional workflow.
How bills become lawAll actionsIntroduced16 months
Passed House
Passed Senate
Sent to President
Signed into law
Expired
- Sponsor
- Rep. Michael C. Burgess (R-TX-26)
- Cosponsors
3 cosponsors
2 original · 1 later
- Rep. Earl L. "Buddy" Carter (R-GA-1)· Original · Jun 7, 2023
- Rep. Danny K. Davis (D-IL-7)· Original · Jun 7, 2023
- Rep. Barbara Lee (D-CA-12)· Later · Jul 19, 2023
- Policy area
- Health
- Subjects
- Blood and blood diseases
- Health programs administration and funding
- Health promotion and preventive care
- Hereditary and development disorders
- Medical research
On this page
Timeline
i
In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.
Introduced in House
Document: Introduced in House
Sources
- Congress.gov actionIntro-H
- Library of Congress
▸ 7 committee actions · Jun 7, 2023 – Aug 25, 2023
Referred to committee
Referred to the House Committee on Energy and Commerce.
Sources
- Congress.gov action
- House floor actions
Referred to Health
Referred to the Subcommittee on Health.
Sources
- Congress.gov action
- House committee actions
Subcommittee markup session held
Subcommittee Consideration and Mark-up Session Held
Sources
- Congress.gov action
- House committee actions
Forwarded by subcommittee
Forwarded by Subcommittee to Full Committee (Amended) by the Yeas and Nays: 28 - 0.
Sources
- Congress.gov action
- House committee actions
Markup session held
Committee Consideration and Mark-up Session Held.
Sources
- Congress.gov action
- House committee actions
Ordered reported
Ordered to be Reported (Amended) by the Yeas and Nays: 50 - 0.
Sources
- Congress.gov action
- House committee actions
Reported by committee
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 118-166.
Sources
- Congress.gov action
- House floor actions
Passed House
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.
The House passed the bill as amended.
Document: Engrossed in House
Sources
- Congress.gov action
- House floor actions
- Latest
Referred to committee
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sources
- Congress.gov action
- Senate
Expired
Passed House → Referred to Senate Health, Education, Labor, and Pensions → No further action before the 118th Congress ended.
Committees
- HouseEnergy and CommerceReferred Jun 7, 2023 · Markup Jul 19, 2023 · Reported Aug 25, 2023H. Rept. 118-166
Jul 19, 2023 · Markup
Jul 13, 2023 · Markup
Jun 14, 2023 · Meeting
Floor record
i
Explicit consideration evidence: the measure’s bill-status citation matched a GovInfo title, headline, or first paragraph. Incidental mentions are not listed.
Sep 23, 2024 · House · Considered under suspension of the rulesCongressional Record H5578–H5580
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023
Text & titles
i
Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.
| Version | Date | Links |
|---|---|---|
| Introduced in House | ||
| Reported in House | ||
| Engrossed in House | ||
| Referred in Senate |
Titles (2)
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023
Short title, Display title · Referred in Senate, Engrossed in House, Introduced in House, Reported in House
To amend title XI of the Public Health Service Act to reauthorize the program providing for sickle cell disease and other heritable blood disorders research, surveillance, prevention, and treatment.
Official title · Introduced in House